Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, Carter R, Gibson A, Holmes M, Clayton B, Rogers Z, McParland L, Conner M, Glidewell L, Woroncow B, Dawkins B, Dickinson S, Hulme C, Brown J, Velikova G. Absolom K, et al. Among authors: carter r. J Clin Oncol. 2021 Mar 1;39(7):734-747. doi: 10.1200/JCO.20.02015. Epub 2021 Jan 8. J Clin Oncol. 2021. PMID: 33417506 Free article. Clinical Trial.
Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy.
Dawkins B, Absolom K, Hewison J, Warrington L, Hudson E, Holch P, Carter R, Gibson A, Holmes M, Rogers Z, Dickinson S, Morris C, Woroncow B, Brown J, Hulme C, Velikova G. Dawkins B, et al. Among authors: carter r. JCO Oncol Pract. 2024 Apr;20(4):581-590. doi: 10.1200/OP.23.00498. Epub 2024 Jan 24. JCO Oncol Pract. 2024. PMID: 38266205 Free article. Clinical Trial.
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S, Yue H, Myers JA, Carter RD, Robertson AN, Mittal P, Zhu Z, Hansen BS, Donovan KA, Hunkeler M, Rosikiewicz W, Wu Z, McReynolds MG, Roy Burman SS, Schmoker AM, Mageed N, Brown SA, Mobley RJ, Partridge JF, Stewart EA, Pruett-Miller SM, Nabet B, Peng J, Gray NS, Fischer ES, Roberts CWM. Radko-Juettner S, et al. Among authors: carter rd. Nature. 2024 Apr 29. doi: 10.1038/s41586-024-07402-3. Online ahead of print. Nature. 2024. PMID: 38684813 No abstract available.
Benchmark dose profiles for bivariate exposures.
Akkaya Hocagil T, Ryan LM, Cook RJ, Dang KD, Carter RC, Richardson GA, Day NL, Coles CD, Carmichael Olson H, Jacobson SW, Jacobson JL. Akkaya Hocagil T, et al. Among authors: carter rc. Risk Anal. 2024 Apr 23. doi: 10.1111/risa.14303. Online ahead of print. Risk Anal. 2024. PMID: 38651726
3,453 results